Your browser doesn't support javascript.
loading
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.
Kommoss, Stefan; Winterhoff, Boris; Oberg, Ann L; Konecny, Gottfried E; Wang, Chen; Riska, Shaun M; Fan, Jian-Bing; Maurer, Matthew J; April, Craig; Shridhar, Viji; Kommoss, Friedrich; du Bois, Andreas; Hilpert, Felix; Mahner, Sven; Baumann, Klaus; Schroeder, Willibald; Burges, Alexander; Canzler, Ulrich; Chien, Jeremy; Embleton, Andrew C; Parmar, Mahesh; Kaplan, Richard; Perren, Timothy; Hartmann, Lynn C; Goode, Ellen L; Dowdy, Sean C; Pfisterer, Jacobus.
Afiliação
  • Kommoss S; Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.
  • Winterhoff B; Division of Gynecologic Surgery, Mayo Clinic, Minnesota.
  • Oberg AL; Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, University of Minnesota, Minnesota.
  • Konecny GE; Department of Health Sciences Research, Mayo Clinic, Minnesota.
  • Wang C; Division of Medical Oncology, UCLA, California.
  • Riska SM; Department of Health Sciences Research, Mayo Clinic, Minnesota.
  • Fan JB; Department of Health Sciences Research, Mayo Clinic, Minnesota.
  • Maurer MJ; AnchorDx Corporation, Guangzhou, China.
  • April C; Illumina Inc., San Diego, California.
  • Shridhar V; Department of Health Sciences Research, Mayo Clinic, Minnesota.
  • Kommoss F; Illumina Inc., San Diego, California.
  • du Bois A; Department of Laboratory Medicine, Mayo Clinic, Minnesota.
  • Hilpert F; Institute of Pathology, Mannheim, Germany.
  • Mahner S; Kliniken Essen Mitte (KEM), Deptartment of Gynecology and GynecologicOncology, Essen, Germany.
  • Baumann K; Department of Gynecology and Obstetrics, Schleswig-Holstein University, Kiel, Germany.
  • Schroeder W; Department of Obstetrics and Gynecology, Ludwig Maximillian University Munich, Germany.
  • Burges A; Department of Gynecology and Gynecologic Oncology, Philipps University Marburg, Germany.
  • Canzler U; Gynaecologicum Bremen, Bremen, Germany.
  • Chien J; Klinikum der Universitaet Muenchen, Campus Grosshadern, Klinik und Poliklinik fuer Frauenheilkunde und Geburtshilfe, Munich, Germany.
  • Embleton AC; Department of Gynecology and Obstetrics, Technical University Dresden, Dresden, Germany.
  • Parmar M; Department of Cancer Biology, University of Kansas Cancer Center, Kansas City, Kansas.
  • Kaplan R; Medical Research Council Clinical Trials Unit at University College London, UK.
  • Perren T; Medical Research Council Clinical Trials Unit at University College London, UK.
  • Hartmann LC; Medical Research Council Clinical Trials Unit at University College London, UK.
  • Goode EL; Leeds Institute of Cancer Medicine and Pathology, University of Leeds, UK.
  • Dowdy SC; Division of Medical Oncology, Mayo Clinic, Minnesota.
  • Pfisterer J; Department of Health Sciences Research, Mayo Clinic, Minnesota.
Clin Cancer Res ; 23(14): 3794-3801, 2017 Jul 15.
Article em En | MEDLINE | ID: mdl-28159814
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Bevacizumab Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Biomarcadores Tumorais / Bevacizumab Idioma: En Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha